Metropolitan Life Insurance Company (MetLife)’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,410
| Closed | -$31.2K | – | 520 |
|
|
2024
Q1 | $31.2K | Hold |
1,410
| – | – | ﹤0.01% | 1645 |
|
|
2023
Q4 | $30.4K | Hold |
1,410
| – | – | ﹤0.01% | 1713 |
|
|
2023
Q3 | $23.8K | Hold |
1,410
| – | – | ﹤0.01% | 1805 |
|
|
2023
Q2 | $19.3K | Hold |
1,410
| – | – | ﹤0.01% | 1947 |
|
|
2023
Q1 | $32K | Hold |
1,410
| – | – | ﹤0.01% | 1633 |
|
|
2022
Q4 | $33.2K | Hold |
1,410
| – | – | ﹤0.01% | 1732 |
|
|
2022
Q3 | $36.8K | Hold |
1,410
| – | – | ﹤0.01% | 1663 |
|
|
2022
Q2 | $31K | Hold |
1,410
| – | – | ﹤0.01% | 1797 |
|
|
2022
Q1 | $63.3K | Sell |
1,410
-4,565
| -76% | -$205K | ﹤0.01% | 1460 |
|
|
2021
Q4 | $256K | Hold |
5,975
| – | – | ﹤0.01% | 1844 |
|
|
2021
Q3 | $397K | Hold |
5,975
| – | – | 0.01% | 1602 |
|
|
2021
Q2 | $438K | Buy |
5,975
+1,748
| +41% | +$128K | 0.01% | 1601 |
|
|
2021
Q1 | $289K | Buy |
4,227
+968
| +30% | +$66.3K | ﹤0.01% | 1768 |
|
|
2020
Q4 | $219K | Hold |
3,259
| – | – | ﹤0.01% | 1878 |
|
|
2020
Q3 | $168K | Hold |
3,259
| – | – | ﹤0.01% | 1894 |
|
|
2020
Q2 | $123K | Hold |
3,259
| – | – | ﹤0.01% | 2129 |
|
|
2020
Q1 | $97.2K | Buy |
+3,259
| New | +$97.2K | ﹤0.01% | 2045 |
|